Vera Therapeutics, Inc. (VERA)

Vera Therapeutics Statistics

Total Valuation

VERA has a market cap or net worth of $2.91 billion. The enterprise value is $2.27 billion.

Market Cap	2.91B
Enterprise Value	2.27B

Important Dates

The last earnings date was Thursday, February 26, 2026, before market open.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

VERA has 71.36 million shares outstanding. The number of shares has increased by 16.10% in one year.

Current Share Class	71.36M
Shares Outstanding	71.36M
Shares Change (YoY)	+16.10%
Shares Change (QoQ)	+2.79%
Owned by Insiders (%)	0.87%
Owned by Institutions (%)	90.31%
Float	55.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.43
P/TBV Ratio	4.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.64, with a Debt / Equity ratio of 0.13.

Current Ratio	13.64
Quick Ratio	13.37
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -50.71% and return on invested capital (ROIC) is -30.02%.

Return on Equity (ROE)	-50.71%
Return on Assets (ROA)	-28.36%
Return on Invested Capital (ROIC)	-30.02%
Return on Capital Employed (ROCE)	-46.31%
Weighted Average Cost of Capital (WACC)	10.32%
Revenue Per Employee	n/a
Profits Per Employee	-$1.34M
Employee Count	224
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, VERA has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +46.89% in the last 52 weeks. The beta is 1.15, so VERA's price volatility has been higher than the market average.

Beta (5Y)	1.15
52-Week Price Change	+46.89%
50-Day Moving Average	46.35
200-Day Moving Average	31.25
Relative Strength Index (RSI)	40.03
Average Volume (20 Days)	983,101

Short Selling Information

The latest short interest is 8.03 million, so 11.26% of the outstanding shares have been sold short.

Short Interest	8.03M
Short Previous Month	8.09M
Short % of Shares Out	11.26%
Short % of Float	14.60%
Short Ratio (days to cover)	7.33

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-315.47M
Pretax Income	-299.61M
Net Income	-299.62M
EBITDA	-315.03M
EBIT	-315.47M
Earnings Per Share (EPS)	-$4.66

Balance Sheet

The company has $714.59 million in cash and $77.31 million in debt, with a net cash position of $637.28 million or $8.93 per share.

Cash & Cash Equivalents	714.59M
Total Debt	77.31M
Net Cash	637.28M
Net Cash Per Share	$8.93
Equity (Book Value)	604.52M
Book Value Per Share	9.21
Working Capital	675.43M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VERA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.10%
Shareholder Yield	-16.10%
Earnings Yield	-10.29%
FCF Yield	n/a

Analyst Forecast

The average price target for VERA is $76.60, which is 87.79% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$76.60
Price Target Difference	87.79%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a